AbbVie (ABBV) Revenue — Quarter Ended Jun 30, 2023
Revenue increased sequentially but declined year over year. The quarter showed a rebound from the prior period's decline.
Key takeaway
Quarter ended Jun 30, 2023 · FY2023 Q2
Revenue increased sequentially but declined year over year. The quarter showed a rebound from the prior period's decline.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$13.9B
Revenue reported for this quarter.
Quarter-over-quarter
+13.4%
Change from the immediately preceding quarter.
Year-over-year
-4.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$56B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2022 | $14.8B | +3.3% |
| Dec 31, 2022 | $15.1B | +1.6% |
| Mar 31, 2023 | $12.2B | -9.7% |
| Jun 30, 2023 | $13.9B | -4.9% |
Revenue performance
Revenue rose compared to the previous quarter, marking a recovery after a weaker first quarter.
Quarterly comparison
Compared to the immediately preceding quarter, revenue increased. However, revenue was lower than the same quarter one year earlier.
What to watch
Monitor whether the sequential revenue growth can be sustained amid the year-over-year decline.